• Our Mission
  • Clinical Trials Scoreboard
  • What is Congress Doing?
  • Contact Us

Idiopathic Pulmonary Fibrosis

Latest News in Idiopathic Pulmonary Fibrosis


April 17, 2026

Hdac11 promotes idiopathic pulmonary fibrosis through macrophage M2-type polarization and myofibroblast accumulation by inhibiting Parkin-dependent mitophagy – Nature


April 2, 2026

Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis – Yahoo Finance


April 1, 2026

FTIR imaging identifies alterations in lung tissue structure and biochemical composition in human idiopathic pulmonary fibrosis – Nature


March 24, 2026

Avalyn initiates Phase II AURA trial for idiopathic pulmonary fibrosis – Clinical Trials Arena


March 13, 2026

Nintedanib Lacks Efficacy in a Spirometry-Confirmed and Bleomycin-Induced Mouse Model of Idiopathic Pulmonary Fibrosis – Wiley Online Library

  • «
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 19
  • »

28 Active Idiopathic Pulmonary Fibrosis Clinical Trials

As of

Source: clinicaltrials.gov

Click here to see other conditions

LOCATE

CLINICAL TRIALS

BROWSE

FDA-approved DRUGS

WHAT IS

CONGRESS DOING?

© Copyright 2020-2026 Seeking Cure, Inc. All Rights Reserved. Third Party materials included herein protected under copyright law.

Seeking Cure is a registered trademark of Seeking Cure, Inc.

Use of this website and any information contained herein is governed by Seeking Cure’s Terms of Service and Privacy Policy. This website is provided for general information purposes only. This website does not provide medical advice. Always consult an appropriately licensed medical provider for diagnosis and treatment. Seeking Cure does not warrant the accuracy, completeness, or timeliness of the information. Content and other features are subject to change or termination without notice at the discretion of Seeking Cure.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • Follow
  • Follow

You are now leaving the Seeking Cure website. Seeking Cure offers links to other third party websites that may be of interest to our website visitors. Seeking Cure is not responsible for the products, services, and content on the third party website. We make no representation or warranty regarding the accuracy of the information contained in the linked sites.

Also, please be aware that the security and privacy policies on these sites may be different than Seeking Cure’s policies. When you use a third party site, you will be subject to its terms and licenses.

By clicking on the CONTINUE button below, you acknowledge the above statement and will be taken to the linked site.

Continue

We use cookies to improve your experience on our website. By continuing to use this website, you agree to our Terms of Service and Privacy Policy. To learn more about how we use cookies, please see our Privacy Policy.